I agree that this site is using cookies. You can find further informations here.
X
Naik, Jaesh
15  results:
Search for persons X
?
1

Cost-Effectiveness of Lorlatinib for the Treatment of Adult..:

Presa, María ; Vicente, David ; Calles, Antonio...
ClinicoEconomics and Outcomes Research.  15 (2023)  - p. 659-671 , 2023
Link: https://doi.org/10.2147/..
 
?
2

Cost‑Effectiveness of Lorlatinib in First-Line Treatment of..:

Naik, Jaesh ; Beavers, Norma ; Nilsson, Fredrik O. L...
Applied Health Economics and Health Policy.  21 (2023)  4 - p. 661-672 , 2023
Link: https://doi.org/10.1007/..
 
?
3

Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compar..:

Yang, Joe ; Naik, Jaesh ; Massello, Matthew..
Infectious Diseases and Therapy.  , 2022
Link: https://doi.org/10.1007/..
 
?
4

Correction to: Cost-Effectiveness of Imipenem/Cilastatin/Re..:

Yang, Joe ; Naik, Jaesh ; Massello, Matthew..
Infectious Diseases and Therapy.  , 2022
Link: https://doi.org/10.1007/..
 
?
5

Cost Effectiveness of Ceftolozane/Tazobactam Compared with ..:

Naik, Jaesh ; Puzniak, Laura ; Critchlow, Simone...
Infectious Diseases and Therapy.  10 (2021)  2 - p. 939-954 , 2021
Link: https://doi.org/10.1007/..
 
?
6

631. Economic Analysis of Imipenem/Cilastatin/Relebactam Co..:

Naik, Jaesh ; Massello, Matthew ; Ralph, Lewis..
Open Forum Infectious Diseases.  8 (2021)  Supplement_1 - p. S419-S419 , 2021
Link: https://doi.org/10.1093/..
 
?
7

2200. Cost-effectiveness of Ceftolozane/Tazobactam for Trea..:

Naik, Jaesh ; Yang, Joe ; Elsea, David..
Open Forum Infectious Diseases.  6 (2019)  Supplement_2 - p. S749-S750 , 2019
Link: https://doi.org/10.1093/..
 
?
8

Cost‑Effectiveness of Lorlatinib in First-Line Treatment of..:

Naik, Jaesh ; Beavers, Norma ; Nilsson, Fredrik O. L..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232573/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
9

Cost–effectiveness of imipenem/cilastatin/relebactam for ho..:

Naik, Jaesh ; Dillon, Ryan ; Massello, Matthew..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288960/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
10

Cost-Effectiveness of Lorlatinib for the Treatment of Adult..:

Presa, María ; Vicente, David ; Calles, Antonio...
info:eu-repo/semantics/altIdentifier/doi/10.2147/CEOR.S415711.  , 2023
Link: https://www.dovepress.co..
 
?
11

Cost-Effectiveness of Lorlatinib for the Treatment of Adult..:

Presa, María ; Vicente, David ; Calles, Antonio...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494862/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
12

Cost Effectiveness of Ceftolozane/Tazobactam Compared with ..:

Naik, Jaesh ; Puzniak, Laura ; Critchlow, Simone...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034281/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
13

2200. Cost-effectiveness of Ceftolozane/Tazobactam for Trea..:

Naik, Jaesh ; Yang, Joe ; Elsea, David..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809691/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
14

Cost–effectiveness of imipenem/cilastatin/relebactam for ho..:

Jaesh Naik ; Ryan Dillon ; Matthew Massello..
https://doaj.org/toc/2042-6313.  , 2023
Link: https://doi.org/10.2217/..
 
?
15

Cost Effectiveness of Ceftolozane/Tazobactam Compared With ..:

Adis journals on behalf of (9646730) ; Jaesh Naik (10304216) ; Laura Puzniak (5482958)...
https://figshare.com/articles/figure/Cost_Effectiveness_of_Ceftolozane_Tazobactam_Compared_With_Meropenem_for_the_Treatment_of_Patients_With_Ventilated_Hospital-Acquired_Bacterial_Pneumonia_and_Ventilator-Associated_Bacterial_Pneumonia/14216423.  , 2021
Link: https://doi.org/10.6084/..
 
1-15